Lung cancer articles within Gene Therapy

Featured

• Article
  22 March 2022 | Open Access

  Exon skipping induced by CRISPR-directed gene editing regulates the response to chemotherapy in non-small cell lung carcinoma cells

  • Kelly Banas
  • , Shirin Modarai
  •  & Eric B. Kmiec

• Article | 22 August 2019

  Bicistronic transfer of CDKN2A and p53 culminates in collaborative killing of human lung cancer cells in vitro and in vivo

  • Juliana G. Xande
  • , Ana P. Dias
  •  & Eugenia Costanzi-Strauss

• Original Article | 19 January 2018

  CCAT1 stimulation of the symmetric division of NSCLC stem cells through activation of the Wnt signalling cascade

  • C Xu
  • , G Xiao
  •  & X Sun

• Original Article | 17 August 2015

  The targeted inhibitory effects of human amniotic fluid stem cells carrying CXCR4 promoter and DAL-1 on non-small cell lung carcinoma growth

  • L Li
  • , S Li
  •  & Y Zhang

• Original Article | 31 July 2014

  DNA vaccine elicits an efficient antitumor response by targeting the mutant Kras in a transgenic mouse lung cancer model

  • T-Y Weng
  • , M-C Yen
  •  & M-D Lai

• Original Article | 06 March 2014

  Efficient lung orthotopic tumor-growth suppression of oncolytic adenovirus complexed with RGD-targeted bioreducible polymer

  • J Kim
  • , H Y Nam
  •  & S W Kim

• Original Article | 28 November 2013

  Intratumoral gene therapy versus intravenous gene therapy for distant metastasis control with 2-Diethylaminoethyl-Dextran Methyl Methacrylate Copolymer Non-Viral Vector–p53

  • A Baliaka
  • , P Zarogoulidis
  •  & L Sakkas

• Short Communication | 30 May 2013

  2-diethylaminoethyl-dextran methyl methacrylate copolymer nonviral vector: still a long way toward the safety of aerosol gene therapy

  • P Zarogoulidis
  • , W Hohenforst-Schmidt
  •  & K Zarogoulidis

• Original Article | 27 October 2011

  S100A2 promoter-driven conditionally replicative adenovirus targets non-small-cell lung carcinoma

  • K Lee
  • , S-T Yun
  •  & E-C Jo

• Original Article | 01 July 2010

  AAVrh.10-mediated genetic delivery of bevacizumab to the pleura to provide local anti-VEGF to suppress growth of metastatic lung tumors

  • M Watanabe
  • , J L Boyer
  •  & R G Crystal

• Original Article | 01 July 2010

  Addition of adenoviral vector targeting of chemotherapy to the MUC-1/ecdCD40L VPPP vector prime protein boost vaccine prolongs survival of mice carrying growing subcutaneous deposits of Lewis lung cancer cells

  • H Akbulut
  • , Y Tang
  •  & A Deisseroth